What is 4DMedical Limited (FDMDF)?

4DMedical Limited (FDMDF) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of FDMDF?

The current price of FDMDF is $1.95. Prices are updated in real time on Stocks360.

What is FDMDF's price-to-earnings (PE) ratio?

FDMDF's trailing twelve-month PE ratio is -6.19, based on current price and earnings per share data available on Stocks360.

What is FDMDF's market capitalization?

FDMDF's market capitalization is $1,174,365,083.00, placing it in the small-cap tier.

4DMedical Limited (FDMDF)

Stock analysis · OTC · Healthcare · Medical - Devices

$1.95

Market Cap

$1.17B

PE (TTM)

-6.19

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.97

Day Range

$1.95 – $1.95

52-wk Range

$0.87 – $5.00

Avg Volume

N/A

Volume

250.00

4DMedical Limited (FDMDF) is a publicly traded company in the Healthcare sector. Latest price: $1.95. Market cap $1.17B. Trailing PE -6.19. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 14 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $1.12 2026-10-30 · $1.95 (+74.11%)

Earnings

Most Recent

Aug 27, 2026

EPS $0.16 vs est. $-0.03

Beat by $0.19

Next Earnings

Feb 26, 2027

EPS estimate $-0.02

Proprietary Signals

Signal snapshot temporarily unavailable.

About 4DMedical Limited

4DMedical Limited operates as a medical technology firm with operations spanning both Australia and the United States. A core aspect of its business involves the commercialization of XV Technology, an advanced four-dimensional system for lung imaging. The company's offerings further extend to a software-as-a-service (SaaS) delivery model, alongside its proprietary XV lung ventilation analysis software. Additional products include Permetium, a preclinical imaging system designed to quantify localized changes in pulmonary function, and the AccuVent 200, a ventilator specifically tailored for small animals. Established in 2012, 4DMedical Limited is headquartered in Carlton, Australia.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-6.19×
P/S (TTM)	208.09×
P/B	8.57×
PEG	0.01×
P/FCF (TTM)	-45.60×
EV / EBITDA	-22.97×
EV / Sales	169.19×
Earnings Yield	-14.03%
Free Cash Flow Yield	-2.19%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$1.19B
Revenue (TTM)	$7.06M
Net Income (TTM)	-$206.12M
Free Cash Flow (TTM)	-$29.89M
Net Debt	-$274.74M
Working Capital	$280.54M
Gross Margin	-539.23%
Operating Margin	-813.68%
Net Margin	-2895.06%
Return on Equity	-288.42%
Return on Invested Capital	-15.65%